The Bcl-2 repertoire of mesothelioma spheroids underlies acquired apoptotic multicellular resistance
Open Access
- 23 June 2011
- journal article
- research article
- Published by Springer Nature in Cell Death & Disease
- Vol. 2 (6) , e174
Abstract
Three-dimensional (3D) cultures are a valuable platform to study acquired multicellular apoptotic resistance of cancer. We used spheroids of cell lines and actual tumor to study resistance to the proteasome inhibitor bortezomib in mesothelioma, a highly chemoresistant tumor. Spheroids from mesothelioma cell lines acquired resistance to bortezomib by failing to upregulate Noxa, a pro-apoptotic sensitizer BH3-only protein that acts by displacing Bim, a pro-apoptotic Bax/Bak-activator protein. Surprisingly, despite their resistance, spheroids also upregulated Bim and thereby acquired sensitivity to ABT-737, an inhibitor of anti-apoptotic Bcl-2 molecules. Analysis using BH3 profiling confirmed that spheroids acquired a dependence on anti-apoptotic Bcl-2 proteins and were ‘primed for death’. We then studied spheroids grown from actual mesothelioma. ABT-737 was active in spheroids grown from those tumors (5/7, ∼70%) with elevated levels of Bim. Using immunocytochemistry of tissue microarrays of 48 mesotheliomas, we found that most (33, 69%) expressed elevated Bim. In conclusion, mesothelioma cells in 3D alter the expression of Bcl-2 molecules, thereby acquiring both apoptotic resistance and sensitivity to Bcl-2 blockade. Mesothelioma tumors ex vivo also show sensitivity to Bcl-2 blockade that may depend on Bim, which is frequently elevated in mesothelioma. Therefore, mesothelioma, a highly resistant tumor, may have an intrinsic sensitivity to Bcl-2 blockade that can be exploited therapeutically.Keywords
This publication has 39 references indexed in Scilit:
- Vorinostat synergistically potentiates MK-0457 lethality in chronic myelogenous leukemia cells sensitive and resistant to imatinib mesylateBlood, 2008
- Mammalian Target of Rapamycin Contributes to the Acquired Apoptotic Resistance of Human Mesothelioma Multicellular SpheroidsJournal of Biological Chemistry, 2008
- Mechanism of Synergy of N-(4-Hydroxyphenyl)Retinamide and ABT-737 in Acute Lymphoblastic Leukemia Cell Lines: Mcl-1 InactivationJNCI: Journal of the National Cancer Institute, 2008
- Advances in the systemic therapy of malignant pleural mesotheliomaNature Clinical Practice Oncology, 2008
- The third dimension bridges the gap between cell culture and live tissueNature Reviews Molecular Cell Biology, 2007
- Bortezomib Inhibits Nuclear Factor-κB–Dependent Survival and Has Potent In vivo Activity in MesotheliomaClinical Cancer Research, 2007
- BCL-2 family regulation by the 20S proteasome inhibitor bortezomibOncogene, 2007
- Functional Linkage between NOXA and Bim in Mitochondrial Apoptotic EventsJournal of Biological Chemistry, 2007
- Noxa Up-regulation and Mcl-1 Cleavage Are Associated to Apoptosis Induction by Bortezomib in Multiple MyelomaCancer Research, 2007
- Preclinical studies of the proteasome inhibitor bortezomib in malignant pleural mesotheliomaCancer Chemotherapy and Pharmacology, 2007